Age-related macular degeneration (AMD) is a major cause of blindness in the United States. Replacement of dead or damaged cells with healthy retinal cells is a very promising approach to the treatment of this, and other, retinal diseases. Our long-term goal is to develop the methods for transplanting retinal pigment epithelial (RPE) cells early in the course of AMD to rescue photoreceptor cells. The central hypothesis of this proposal is that the identification of the immunological mechanisms, which are responsible for RPE transplant rejection, will provide therapeutic targets for inducing long-term graft acceptance. ? The role of CD4+ and CD8+ T cells in rejection will be tested by adoptively transferring them into ? immunodeficient, recombinase (Rag-1) knockout mice before transplantation of allogeneic RPE. The relative contribution of major and minor histocompatibility antigens to RPE rejection will be assessed using recombinant, inbred strains of mice. The mechanisms by which RPE grafts are rejected will be determined using T cell receptor (TCR) transgenic mice and RPE expressing defined transplantation antigens. Activation and proliferation of adoptively transferred TCR transgenic T cells will be tracked in lymph nodes and the eyes of transplant recipients. TCR T cells recovered from the eyes will be analyzed for various functional activities. Finally, the hypothesis that allograft-specific tolerance can prolong survival of RPE in the absence of continuous treatment with immunosuppressive agents will be tested. ? Results from these studies should identify strategies to prevent rejection that can be tested in preclinical models of RPE transplantation. ? ?

Agency
National Institute of Health (NIH)
Institute
National Eye Institute (NEI)
Type
Research Project (R01)
Project #
5R01EY014877-04
Application #
7235606
Study Section
Special Emphasis Panel (ZRG1-AED (01))
Program Officer
Shen, Grace L
Project Start
2004-07-01
Project End
2010-05-31
Budget Start
2007-06-01
Budget End
2010-05-31
Support Year
4
Fiscal Year
2007
Total Cost
$316,800
Indirect Cost
Name
University of Alabama Birmingham
Department
Ophthalmology
Type
Schools of Medicine
DUNS #
063690705
City
Birmingham
State
AL
Country
United States
Zip Code
35294
Schmack, Ingo; Berglin, Lennart; Nie, Xiaoyan et al. (2009) Modulation of choroidal neovascularization by subretinal injection of retinal pigment epithelium and polystyrene microbeads. Mol Vis 15:146-61
Kapp, Judith A; Bucy, R Pat (2008) CD8+ suppressor T cells resurrected. Hum Immunol 69:715-20
Wajchman, Janine R; Zimring, James C; Lake, Jeffrey P et al. (2007) Ovalbumin serves as a neo-transplantation antigen in retinal pigment epithelial cells. Mol Vis 13:1902-11
Kapp, Judith A; Honjo, Kazuhito; Kapp, Linda M et al. (2007) Antigen, in the presence of TGF-beta, induces up-regulation of FoxP3gfp+ in CD4+ TCR transgenic T cells that mediate linked suppression of CD8+ T cell responses. J Immunol 179:2105-14
McKenna, Kyle C; Kapp, Judith A (2006) Accumulation of immunosuppressive CD11b+ myeloid cells correlates with the failure to prevent tumor growth in the anterior chamber of the eye. J Immunol 177:1599-608
Kapp, Judith A; Honjo, Kazuhito; Kapp, Linda M et al. (2006) TCR transgenic CD8+ T cells activated in the presence of TGFbeta express FoxP3 and mediate linked suppression of primary immune responses and cardiac allograft rejection. Int Immunol 18:1549-62
Wen, Jing; McKenna, Kyle C; Barron, Brent C et al. (2005) Use of superparamagnetic microbeads in tracking subretinal injections. Mol Vis 11:256-62